Published in J Comput Assist Tomogr on April 23, 1986
Efficient 3-D TOF PET reconstruction using view-grouped histo-images: DIRECT-direct image reconstruction for TOF. IEEE Trans Med Imaging (2009) 1.12
Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reporting. EJNMMI Res (2013) 0.95
Instrumentation for Time-of-Flight Positron Emission Tomography. Nucl Med Mol Imaging (2016) 0.75
Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab (1990) 6.62
Physical and clinical performance of the mCT time-of-flight PET/CT scanner. Phys Med Biol (2011) 3.14
Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry (1991) 2.89
Coupling between regional blood flow and oxygen utilization in the normal human brain. A study with positron tomography and oxygen 15. Arch Neurol (1983) 2.19
The cortical representation of speech. J Cogn Neurosci (1993) 2.12
Concept of reaction volume in the in vivo ligand-receptor model. J Nucl Med (1996) 2.01
Left prefrontal glucose hypometabolism in the depressed state: a confirmation. Am J Psychiatry (1990) 1.92
Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med (1999) 1.91
Peduncular 'rubral' tremor and dopaminergic denervation: a PET study. Neurology (1995) 1.84
Quantitative imaging of iodine-124 with PET. J Nucl Med (1996) 1.69
Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry (1990) 1.66
Positron emission tomography with 11C CGP-12177 to assess beta-adrenergic receptor concentration in idiopathic dilated cardiomyopathy. Circulation (1993) 1.62
Respective roles of scatter, attenuation, depth-dependent collimator response and finite spatial resolution in cardiac single-photon emission tomography quantitation: a Monte Carlo study. Eur J Nucl Med (1999) 1.59
Clinical impact of (18)F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative (131)I scanning results after therapy. J Nucl Med (2001) 1.55
Canine myocardial beta-adrenergic, muscarinic receptor densities after denervation: a PET study. J Nucl Med (1995) 1.47
Noninvasive quantification of muscarinic receptors in vivo with positron emission tomography in the dog heart. Circulation (1990) 1.47
Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195. Neurology (2000) 1.47
Exercise-induced muscle modifications: study of healthy subjects and patients with metabolic myopathies with MR imaging and P-31 spectroscopy. Radiology (1991) 1.46
Frontal dysfunction in neurologically normal chronic alcoholic subjects: metabolic and neuropsychological findings. Psychol Med (1998) 1.38
Local interrelationships of cerebral oxygen consumption and glucose utilization in normal subjects and in ischemic stroke patients: a positron tomography study. J Cereb Blood Flow Metab (1984) 1.35
Mapping cocaine binding sites in human and baboon brain in vivo. Synapse (1989) 1.29
The right brain hemisphere is dominant in human infants. Brain (1997) 1.27
Delayed maturation of the frontal cortex in childhood autism. Am J Psychiatry (1995) 1.26
Movement- and task-related activations of motor cortical areas: a positron emission tomographic study. Ann Neurol (1994) 1.24
Changes in regional cerebral blood flow during brain maturation in children and adolescents. J Nucl Med (1992) 1.23
In vivo detection of striatal dopamine release during reward: a PET study with [(11)C]raclopride and a single dynamic scan approach. Neuroimage (2002) 1.20
Design and performance of POSICAM 6.5 BGO positron camera. J Nucl Med (1990) 1.18
PET study of carbon-11-PK 11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case report. J Nucl Med (1991) 1.17
Amygdala atrophy in Alzheimer's disease. An in vivo magnetic resonance imaging study. Arch Neurol (1993) 1.15
In vivo imaging of oligonucleotides with positron emission tomography. Nat Med (1998) 1.15
[11C]L-methionine uptake in gliomas. Neurosurgery (1989) 1.11
PET scanning of iodine-124-3F9 as an approach to tumor dosimetry during treatment planning for radioimmunotherapy in a child with neuroblastoma. J Nucl Med (1992) 1.10
Noninvasive tomographic study of cerebral blood flow and oxygen metabolism in vivo. Potentials, limitations, and clinical applications in cerebral ischemic disorders. Eur Neurol (1981) 1.09
Identifiability analysis and parameter identification of an in vivo ligand-receptor model from PET data. IEEE Trans Biomed Eng (1990) 1.08
Body composition determined with MR in patients with Duchenne muscular dystrophy, spinal muscular atrophy, and normal subjects. Magn Reson Imaging (1997) 1.05
Presynaptic dopaminergic function in the striatum of schizophrenic patients. Schizophr Res (1997) 1.04
Early single photon emission computed tomography in Sturge-Weber syndrome. J Neurol Neurosurg Psychiatry (1997) 1.02
Brain tumor protein synthesis and histological grades: a study by positron emission tomography (PET) with C11-L-Methionine. J Neurooncol (1986) 1.01
Analysis of cerebrovascular diseases by a new 3-dimensional computerised X-ray angiography system. Neuroradiology (1998) 1.01
Correction of distortions due to the pulsed magnetic field gradient-induced shift in B0 field by postprocessing. Magn Reson Med (1989) 0.99
Quantification of benzodiazepine receptors in human brain using PET, [11C]flumazenil, and a single-experiment protocol. J Cereb Blood Flow Metab (1995) 0.96
SPECT of the brain in childhood autism: evidence for a lack of normal hemispheric asymmetry. Dev Med Child Neurol (1995) 0.96
The role of positron emission tomography in the detection of pancreatic disease. Radiology (1982) 0.96
Absolute quantification by positron emission tomography of the endogenous ligand. J Cereb Blood Flow Metab (2001) 0.95
Simultaneous temperature and regional blood volume measurements in human muscle using an MRI fast diffusion technique. Magn Reson Med (1993) 0.94
The estimated density of D2 striatal receptors in schizophrenia. A study with positron emission tomography and 76Br-bromolisuride. Br J Psychiatry (1991) 0.93
MR quantification of muscle fatty replacement in McArdle's disease. Magn Reson Imaging (1996) 0.92
Kinetics and displacement of [11C]RO 15-1788, a benzodiazepine antagonist, studied in human brain in vivo by positron tomography. Eur J Pharmacol (1985) 0.92
Beta-adrenergic contractile reserve as a predictor of clinical outcome in patients with idiopathic dilated cardiomyopathy. Am Heart J (1992) 0.92
Impaired cardiac adrenergic innervation assessed by MIBG imaging as a predictor of treatment response in childhood dilated cardiomyopathy. Heart (2001) 0.91
Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method. J Nucl Med (1991) 0.90
A CpG-rich RNA and an RNA helicase tightly associated with the DNA demethylation complex are present mainly in dividing chick embryo cells. Eur J Cell Biol (2000) 0.89
Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach. J Cereb Blood Flow Metab (1999) 0.89
Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart. J Nucl Med (1999) 0.89
Regional cerebral opioid receptor studies with [11C]diprenorphine in normal volunteers. J Neurosci Methods (1988) 0.88
Endothelial uptake of amino acids, sugars, lipids, and prostaglandins in rat lung. Am J Physiol (1982) 0.87
Tomographic mapping of brain intracellular pH and extracellular water space in stroke patients. J Cereb Blood Flow Metab (1985) 0.87
A hybrid scatter correction for 3D PET based on an estimation of the distribution of unscattered coincidences: implementation on the ECAT EXACT HR+. Phys Med Biol (2002) 0.86
The effect of nifedipine on myocardial perfusion and metabolism in systemic sclerosis. A positron emission tomographic study. Arthritis Rheum (1991) 0.86
[11C]methionine pancreatic scanning with positron emission computed tomography. J Nucl Med (1979) 0.86
Specificity of temporal amygdala atrophy in Alzheimer's disease: quantitative assessment with magnetic resonance imaging. Dementia (1996) 0.85
Peripheral-type benzodiazepine receptors in the living heart characterized by positron emission tomography. Circulation (1986) 0.85
Preparation and pharmacological characterization of [76Br]-meta-bromobenzylguanidine ([76Br]MBBG). Nucl Med Biol (1994) 0.85
Diagnosis of muscular glycogenosis by in vivo natural abundance 13C NMR spectroscopy. Neuromuscul Disord (1991) 0.84
Phosphorus NMR spectroscopy study of muscular enzyme deficiencies involving glycogenolysis and glycolysis. Neurology (1987) 0.84
11C-L-methionine for evaluation of pancreatic exocrine function. Gut (1981) 0.84
Rapid measurement of regional cerebral blood flow in the baboon using 15O-labelled water and dynamic positron emission tomography. Med Biol Eng Comput (1993) 0.83
76Br-bromospiroperidol: a new tool for quantitative in-vivo imaging of neuroleptic receptors. Life Sci (1984) 0.83
Robustness of anatomically guided pixel-by-pixel algorithms for partial volume effect correction in positron emission tomography. J Cereb Blood Flow Metab (1999) 0.83
Age-related decreases in muscarinic cholinergic receptor binding in the human brain measured with positron emission tomography (PET). J Neurosci Res (1990) 0.83
Determination of organ volume by single-photon emission tomography. J Nucl Med (1982) 0.83
MR imaging as a potential diagnostic test for metabolic myopathies: importance of variations in the T2 of muscle with exercise. AJR Am J Roentgenol (1993) 0.83
Use of 11C-triphenylmethylphosphonium for the evaluation of membrane potential in the heart by positron-emission tomography. Eur J Nucl Med (1986) 0.83
Modeling analysis of [11C]flumazenil kinetics studied by PET: application to a critical study of the equilibrium approaches. J Cereb Blood Flow Metab (1993) 0.83
Experimental design optimisation: theory and application to estimation of receptor model parameters using dynamic positron emission tomography. Phys Med Biol (1989) 0.83
Fast nonsupervised 3D registration of PET and MR images of the brain. J Cereb Blood Flow Metab (1994) 0.82
Kinetics of the norepinephrine analog [76Br]-meta-bromobenzylguanidine in isolated working rat heart. Nucl Med Biol (1998) 0.82
Regional cerebral blood flow by SPECT imaging in Sturge-Weber disease: an aid for diagnosis. J Neurol Neurosurg Psychiatry (1989) 0.82
Impaired cerebral glucose metabolism in myotonic dystrophy: a triplet-size dependent phenomenon. Neuromuscul Disord (1998) 0.82
Myocardial beta-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy. J Cardiovasc Pharmacol (1992) 0.82
Arrhythmogenic right ventricular dysplasia demonstrated by phase mapping of gated equilibrium radioventriculography. Am Heart J (1986) 0.81
Kinetic analysis of central [76Br]bromolisuride binding to dopamine D2 receptors studied by PET. J Cereb Blood Flow Metab (1991) 0.81
Magnetic resonance imaging to monitor pathology of caudate-putamen after excitotoxin-induced neuronal loss in the nonhuman primate brain. Exp Neurol (1992) 0.81
Parametric images of benzodiazepine receptor concentration using a partial-saturation injection. J Cereb Blood Flow Metab (1997) 0.81
Scintillation splenoportography: hemodynamic and morphological study of the portal circulation. Gastroenterology (1976) 0.81
Muscarinic cholinergic receptor in the human heart evidenced under physiological conditions by positron emission tomography. Proc Natl Acad Sci U S A (1985) 0.81
Kinetics of in vivo binding of antagonist to muscarinic cholinergic receptor in the human heart studied by positron emission tomography. Life Sci (1984) 0.81
Quantification of myocardial muscarinic receptors with PET in humans. J Nucl Med (1993) 0.81
Effects of oxygen breathing on regional distribution of ventilation and perfusion in hypoxemic patients with chronic lung disease. Am Rev Respir Dis (1982) 0.80
The physical performances of a single slice positron tomographic system and preliminary results in a clinical environment. Eur J Nucl Med (1979) 0.80
Remote metabolic effects of cerebrovascular lesions: magnetic resonance and positron tomography imaging. Neuroradiology (1987) 0.80